medical tourism

SINGAPORE (Nov 29): After a 91% surge in its share price since 2016, Health Management International has gained an important new supporter -- a unit of Singapore’s state investment firm.

SINGAPORE (Sept 21): UOB Kay Hian is upgrading its call on Raffles Medical Group (RMG) to “buy” from “hold” with a target price of $1.28.

SINGAPORE (Sept 19): Maybank Kim Eng likes Singapore O&G for its growth strategy of recruiting doctors with potential from the public sector and offering them access to the patient pool.

SINGAPORE (Aug 29): Phillip Capital is maintaining its “buy” recommendation on Health Management International (HMI) at a target price of 83 cents, while expressing a positive view on the group’s FY18 earnings outlook.

SINGAPORE (Aug 28): OCBC Investment Research is maintaining its “buy” recommendation on Health Management International (HMI) with an unchanged fair value estimate of 80 cents.

SINGAPORE (June 5): Maybank Kim Eng Research continues to rate Raffles Medical Group (RMG) at “buy” as Singapore’s leading integrated healthcare provider, with a “robust track record and exciting development plans” of two hospitals in China.

SINGAPORE (March 27): OCBC Investment Research has initiated coverage on Health Management International (HMI) at “buy” with a fair value of 80 cents, advocating the counter as a “healthcare provider with an edge” and one that is set for sustainab

SINGAPORE (Oct 5): Singapore households are expected to double their overseas travel spending to almost US$45 billion ($62 billion) by 2025, placing the country in seventh place globally according to Visa’s report, Mapping the Future of Global Travel an

SINGAPORE (Aug 26): OCBC Investment Research has maintained its “hold” recommendation for Raffles Medical Group with a fair value of $1.54, after taking into account the near-term cost pressures seen in its 2Q results.